The Limited Times

Now you can see non-English news...

"Her words hurt the fourth vaccination campaign": A sharp confrontation between Prof. Ash and Dr. Elrai Price and a senior official from Sheba Hospital | Israel today

2022-03-27T16:23:21.442Z


Difficult exchanges during a discussion of the epidemic treatment team between the director general of the Ministry of Health and Prof. Gili Regev • Participants said: The Sheba experiment: "It is very unpleasant to hear such anger at a professional just because he expresses a different opinion"


Tense discussion and difficult exchanges at the last epidemic of the epidemic treatment team last week.

The discussion dealt, among other things, with the failure of the fourth vaccination campaign, and in preparation for a vaccination campaign for people aged 60 and over.

During this, senior Ministry of Health officials accused Prof. Gili Regev of Sheba of harming the fourth vaccination campaign.

Sources present at the hearing noted that the hearing rose to high tones and that Regev became the "scapegoat" of the operation's failure, in part because she had previously expressed a professional opinion that she was "disappointed" by the results of the fourth vaccine study.

During a discussion of the most senior professionals in the field of fighting in Corona, accusations were made in harsh tones by Dr. Sharon Elrai Price with the backing of the Director General of the Ministry of Health, Prof. Nachman Ash, and also by the Center for Epidemic Treatment.

The discussion raised the issue of the effectiveness of the fourth vaccine dose, during which the experts who intend for the Ministry of Health to continue the information campaign for vaccines aged 60 and over in the fourth dose were updated.

Sheba Hospital, Photo: Coco

Prof. Regev spoke at the discussion and said that the fourth vaccine will not stop the wave and will not reduce serious illness.

At this point, Prof. Ash broke out and said that this was an irresponsible and professionally inaccurate statement, regarding the effect of the vaccine on preventing serious illness.

Those present at the hearing noted that "this was an irresponsible and inaccurate statement and it was obligatory to say the things."


According to sources in the discussion, the person who started the accusations against Prof. Regev was Dr. Tal Brosh, the center of the epidemic treatment team, who said that due to Prof. Regev's statements, populations that needed to be vaccinated also refrained from arriving. The fourth vaccine was lukewarm when a senior figure said that the results of the experiment with the fourth vaccine were disappointing. "

This is what Prof. Regev said in the first phase of the study, in which she stated that the fourth vaccine did not produce high-level antibodies and was less effective against the omicron strain, and especially for last week's publication that "the effectiveness of the vaccine from omicron infection is low."

Vaccine in Sheba (archive), Photo: Coco

"It was a shameful incident," said a source present at the hearing.

Another source present at the hearing said, "Although the entire hearing is underway, it was possible to feel the discomfort of a large part of those present. The feeling was that it was 'aliyahum' on Prof. Regev. Failed when respectable people here talk about disappointing results'.

The message was that it was important that we broadcast on the same wave.

What was in this discussion was completely out of the ordinary professional disagreements that happen in meetings.

This is unusual both because it was high-grade and also because it is a kind of silencing.

That established a section of majority thinking. "

Another source believed that "there was no attempt at silence but criticism of her statement. It was net at the professional level. There was criticism of Sheba's publications and how it appeared in the media and hurt the vaccination campaign. There was debate as to whether these statements were correct at the explanatory level. "Nachman came in in the middle of things. It is rare that there is such a conflict. They found it (Gili Regev) as a scapegoat for the fourth vaccine. As a SG of a systemic problem."

Another source present at the hearing noted that "there was an uproar. Dr. Brosh's statement at the beginning of the hearing was unnecessary.

The fourth-dose vaccination campaign did not fail because of Prof. Regev's statement but because he went the wrong way.

It should have been said that the vaccine is not effective against infection.

People found that even if they did everything they were told and got vaccinated with the three and four vaccine they were still infected.

"There was no sense of gagging in the discussion, but certainly a feeling that there is one line leading and that it is difficult to say a different opinion in the presence of Sharon Elrai Price and the CEO. If this is a committee that advises them, why are they part of the discussion?"

The emerging atmosphere of inability to contain professional disputes runs counter to the position presented only last November by the chairman of the team for the treatment of epidemics, Dr. Boaz Lev.

When he decided not to publicly broadcast the discussion on children's vaccines, he justified the decision on the need for a quality professional discussion.


"We did not want the staff members to refrain from expressing a professional opinion freely. We gathered with an open heart and a willing mind to discuss," he said at the time, expressing concern that filming the hearing would cause "some participants to refrain from speaking freely."

Mashiba stated: "The results of the studies conducted at Sheba Medical Center, led by Prof. Gili Regev-Yohai, are published in the world's leading scientific and medical journals and are presented to decision-makers and the public in full transparency.

"These days, Sheba is at an advanced stage in the trial of Pfizer's vaccine, which is adapted to Omicron and other strains, and we will also present its results in full transparency."

Data from the Ministry of Health show that there has been an increase in the number of vaccinated people in the fourth dose in recent days.

From 250 last weekend to about 700 last weekend.

This follows the wave of morbidity and in parallel with the campaign to encourage immunization among people aged 60 and over carried out by the health funds.

The United Health Insurance Fund reports a 348% increase in demand for the fourth vaccine, for those aged 60 and over in the past week compared to the one before it.

There was also a 226% increase among all ages, compared to last week.

Mali Kusha, head nurse and director of the nursing department at Meuhedet, said: "The risk of people aged 60 and over who did not get vaccinated from omicron is 11 times greater, and if they did not get vaccinated with the fourth vaccine the risk is 4. 83% more severe. , And 94% of the total deaths.

Were we wrong?

Fixed!

If you found an error in the article, we'll be happy for you to share it with us

Source: israelhayom

All life articles on 2022-03-27

You may like

Trends 24h

Life/Entertain 2024-03-28T17:17:20.523Z

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.